一个框架来量化药物基因组治疗一致性和药物反应结果的差异
Ilia Rattsev1,2, James M Stevenson3,4, Casey Overby Taylor1,2,3,5
1Institute for Computational Medicine, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Clinical and translational science
|February 18, 2026
概括
ReGGRx框架有助于评估药物遗传学 (PGx) 准则的通用性. 调查结果显示,代表性不足的群体在避免药物失败方面存在差异,凸显了包容性PGx研究的必要性.
科学领域:
- 药物基因组学 药物基因组学
- 健康差异 在健康上的差异
- 现实世界的数据分析.
背景情况:
- 临床药物遗传学 (PGx) 准则可能不适用于所有患者群体.
- 边缘化群体,包括在生物医学研究 (UBR) 中代表性不足的人群和具有不确定的CYP2C19表型的人群,在PGx益处方面面临潜在的差异.
研究的目的:
- 引入和评估基因组指导处方 (ReGGRx) 的五步实体数据框架.
- 根据使用"我们所有人" (AoU) 研究计划数据对CYP2C19测试的PGx指南评估差异,并从中获益.
主要方法:
- 利用ReGGRx框架和AoU数据分析CYP2C19对抗血小板和抗抑郁药物的测试.
- 测量了避免药物失败的差异,PGx一致治疗的成功几率,以及边缘化群体与非边缘化群体的益处.
主要成果:
- 鉴定了抗抑郁药队列中的差异,UBR个体经历避免药物失败的几率较低.
- 不确定的CYP2C19表型与已知的表型相比,避免药物失败的可能性较低.
- 与非UBR组相比,注射PGx一致治疗的UBR组不太可能避免药物失效.
结论:
- ReGGRx框架对评估PGx指导方针在不同人群中的通用性显示出希望.
- 这些发现强调了需要改进罕见或祖先特异性等位基因的特征,以解决差异.
- 生成的证据可以为药物政策决策提供信息,以实现更公平的PGx实施.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
25
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
25
Pharmacogenetics of Drug Metabolism: Overview
23
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
23
Pharmacogenetics and Pharmacogenomics: Overview
20
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
20
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
18
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Principles of Pharmacogenetics: Types of Genetic Variants
22
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
22

